Clinical Trial Update: Study to Compare Different Formulations of AZD3355 [Phase 1]

View source ↗

Summary

An update on a Phase 1 study comparing different formulations of AZD3355 for gastroesophageal reflux disease. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• AZD3355

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux Disease | Phase 1 | Status: COMPLETED